|
What’s Inside: Tim Scott to Succeed Joe Panetta as Biocom California President and CEO; Life Science Sector Generates $414B Annually in California; Bay Area Companies Face Potential Tax Increases; Recap of Our Inaugural Converge Summit; Upcoming Events; and more.
|
Find the latest news and information impacting the Bay Area life science industry. If you have company news you’d like to share, please get in touch.
|
|
|
|
|
Welcome New Bay Area Members
|
|
|
|
|
|
News from Biocom California
|
Tim Scott to Succeed Joe Panetta as Our Next President and CEO
Last month, we announced that Tim Scott will be the next president and CEO of Biocom California, effective January 1, 2025. He will succeed president and CEO Joe Panetta, who has led the organization for 25 years. Scott has been active on the board of directors for Biocom California since 2010, having served as the board’s chair since 2022. Chair-elect Sabrina Martucci Johnson, president and CEO of Daré Bioscience, will succeed Scott as board chair. Scott has more than 20 years of biotech leadership experience and his deep passion, respect and advocacy for the life science industry will be instrumental in shaping Biocom California’s growth and implementation of its strategic plan.
Life Science Industry in California Generates $414.2 Billion Annually
In our recently released Biocom California 2024 Life Science Economic Impact Report, we found that the life science industry in California directly provides more than 465,000 jobs in the state and generates $414.2 billion in total business output. “California has always been a leader in life science innovation, and our 2024 Economic Impact Report shows the sustained value of the industry to the state’s economy,” said Joe Panetta, president and CEO of Biocom California. Other key findings about the state’s life science industry, including information on economic, demographic, investment and industry performance data, can be found in the full report analysis and regional fact sheets.
Inaugural Converge Summit Recap
Last month, more than 120 biotech and tech executives gathered in South San Francisco for our inaugural Converge Summit—highlighting our new cross-sector community advancing human health through life science and tech collaboration. The executive-level summit featured panel sessions and fireside chats led by industry experts from Atomwise, Eli Lilly, Gilead, Unlearn.AI, Iambic Therapeutics and Microsoft, and topics ranging from how AI is transforming drug discovery and healthcare delivery, to the opportunities for significant impact on industry ESG goals. Read the highlights from the summit and join the Converge by Biocom California group on LinkedIn to continue the conversation.
|
|
|
|
Bay Area Companies Facing Potential Tax Increases
Five Bay Area cities are seeking to increase business taxes as they continue to face pandemic-related budget shortfalls. Policies are being considered for the November ballot in San Francisco, South San Francisco, Redwood City, Foster City and Belmont. South San Francisco is proposing changes to its current Business License Tax, whereas Redwood City and Belmont are looking to move toward a Gross Receipts Tax model. Foster City is reforming its current Gross Receipts Tax structure, and in San Francisco, biotech companies could see an 18% tax increase if approved by voters. Biocom California is actively engaged in advocating on behalf of our members in these cities. Please contact Bay Area Policy Manager Christy Shirilla with any questions.
New Speakers Series with City of SSF: What’s Happening East of 101?
Biocom California is excited to partner with the City of South San Francisco on the launch of “What’s Happening East of 101?”—a speaker series that aims to bridge the gap between South City residents and the vibrant biotech community east of Highway 101. Residents will gain insight into the important work life science companies are doing within their city limits—providing solutions for patients globally and right here at home. For more information, please reach out to Brandon Jenkins.
|
|
In Other News:
|
|
|
Capital Development & Partnering
|
Venture Hub Showcase Debuts at BIO 2024 and Upcoming Opportunities
Congratulations to the six Biocom California member companies—MyoGene Bio, Nano PharmaSolutions, NoraChem, NovoMedix, Medific and VSPharmTech—who pitched their innovations to more than 100 attendees at the BIO 2024 Convention. This event marked the debut of Venture Hub Showcase, our new capital development program suite. We will share more details soon, stay updated by subscribing to the quarterly Venture Hub newsletter.
Upcoming C-Suite Events
June 26 | CEO/Founders Network | Alameda – all C-Suite executives are welcome
July 18 | C-Suite Summer Soiree | San Francisco
July 25 | CEO/Founders Network | Brisbane
October 25 | CEO Summit | Sonoma
|
|
|
|
Biocom California Institute and Santa Clara University Host NIIMBL eXperience
Biocom California Institute is partnering with Santa Clara University on the NIIMBL eXperience, an exclusive paid immersion program for students on June 25. Community college students and underrepresented freshmen and sophomores in STEM will visit manufacturing sites, attend panels and meet with life science professionals. The program includes coaching on personal branding, resume development, networking and mock interviews. We are grateful to all the volunteers supporting this transformative program. To learn more about this program and future volunteer opportunities contact Sylwia Palczewska.
|
|
|
|
Portfolio Update
Core by Biocom California (formerly Biocom California Purchasing Group) and Fisher Scientific teams are proud to provide Biocom California members with the products, programs and services they need to succeed. In support of this, we added two additional resource pages to our savings portfolio in order to capture the full extent of the resources available to our members through the Fisher Scientific channel. Explore the two new landing pages below and reach out to your account manager with any questions.
A Look at FedEx’s Leading ESG Initiatives
FedEx released their 2024 ESG Report which outlines their achievements and advancements toward their environmental, social and governance (ESG) strategies, objectives and initiatives. This report highlights their commitment to ESG leadership in the transportation and logistics industry and reflects their dedication to their core values and goals. Read the report here.
Open House & Supplier Showcase Series
Core by Biocom California is excited to invite you to our highly anticipated annual Open House and Supplier Showcase series held at Chandlery at the Shore in Brisbane on August 21. Step into the nostalgic world of classic video games while you explore exclusive savings programs designed with our members in mind. Discover how you can significantly lower your operational costs through our best-in-class suppliers while enjoying hand-crafted cocktails and tasty appetizers and networking with fellow life science professionals. Register here.
|
|
|
|
|
Premium Member News
|
|
|
|
Member News
|
|
|
|
|
Biocom California | Bay Area
Biocom California is the advocate for California’s life science sector. Our South San Francisco office aims to build the networks that are critical to growth in this thriving regional ecosystem. Our targeted programs and customized services are tailored to the specific needs of the Bay Area region. We work on behalf of more than {{{dynamic_content_1600}}} members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs, and create robust value-driven purchasing programs.
|
|
|
